Ramipril, a common blood pressure medication, is being recalled due to contamination fears linked to ingredients from an unregulated manufacturer in India. The recall affects 2.5 mg, 5 mg, and 10 mg capsules made by Lupin Pharmaceuticals, with expiration dates up to July 2026.
Over 600,000 bottles sold by 30 vendors are impacted, including 350,000 bottles of 10 mg capsules.Although the FDA rates this recall as Class 2 (low risk), patients should check their medication and dispose of or return affected bottles for replacement. No adverse effects have been reported so far. This serves as a reminder to regularly check prescriptions for recalls to ensure safety.
